Here are five things to know:
1. With the launch of Arrowhead’s Total Joint Rejuvenation Program, the center is now offering a proprietary regenerative cell therapy for the treatment of large joint osteoarthritis as well as degenerative spinal conditions.
2. The non-surgical outpatient procedure is performed under pain specialists Matthew Crooks, MD, and Deepesh Shah, MD.
3. The procedure utilizes Skye Biologics PX50, an injectable regenerative tissue matrix derived from maternal placental tissue donated after a healthy, live birth, yielding healthy tissue rich in proteins, growth factors, hyaluronic acid, cytokines and other natural cells that heal soft tissue damage.
4. As opposed to steroid injections, placental tissue injections focus on harnessing the body’s natural regenerative power to transform damaged tissue into healthy tissue.
5. Patients suffering from any kind of joint, tendon or ligament pain in any area of their body may be considered candidates for Arrowhead Health Centers’ Total Joint Rejuvenation Program.
More articles on spine:
Turning the ‘art of medicine’ into evidence-based spine care — Key thoughts from Dr. Lawrence Lenke
St. Luke’s Health Care System opens interventional pain management clinic — 5 notes
Florida Mayo Clinic to construct 2 new buildings, neurosurgery floor: 6 highlights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
